摘要
分析巴曲酶治疗平坦型突发性耳聋联合应用甲泼尼龙的疗效。巴曲酶+激素组,共38例,平均听阈75.1dB。巴曲酶组,共16例,平均听阈74.7dB。两组治疗前后平均听阈差无统计学差异(t=0.063,P>0.05)。提示联合应用甲泼尼龙(24mg,5天)对巴曲酶治疗平坦型突发性耳聋不能降低患者治疗后听阈。
To analysis the clinical effect of batroxobin combine with methylprednisolone to treat sudden deafness with flat audiogram. The cases were divided into two groups by their condition and will, Group A: Batroxobin+ oral group, 38 cases, the average of pretherapy auditory threshold was 75. ldB. Group B: Batroxobin group, 16 cases, the average of pre- therapy auditory threshold was 74.7dB. The difference of the decrease was also considered no significant(t= 0. 063, P〉 0.05 ). Associated with methylprednisolone(24mg, 5 days) to treatment sudden hearing loss with flat audiogram with batr- oxobin could not decrease the auditory threshold.
出处
《医学与哲学(B)》
2012年第8期36-37,共2页
Medicine & Philosophy(B)
关键词
突发性耳聋
巴曲酶
甲泼尼龙
sudden deafness, batroxobin, methylprednisolone